Our Speakers

axunio – empowering the overlooked patient

In this presentation, we would like to present our company. We, axunio Pharma GmbH, sell and promote pharmaceuticals in our home market Germany, as well as in the UK, Scandinavia, and the Netherlands. We launched our first product in 2016 and have accomplished major milestones ever since. Our mission is to identify minority needs, which tend to be overlooked. Therefore, we are continuously looking for niche and/or value-added products to in-license or acquire (including the brand). The latter applies to UK in particular, as we are planning to open up our own office there. We believe in targeted and outside-the-box marketing approaches that are built on thorough market analysis and close relationships with KOL from the respective medical areas.

Julia Von Horsten, Business Development Manager, axunio Pharma GmbH

Ina Kühnemund, Managing Director, axunio Pharma GmbH

Farmasyn : “We put the patient first”

FarmaSyn S.A. is a company committed to delivering innovative, accessible, and reliable therapeutic solutions. Established in 1994, FarmaSyn has grown through strategic alliances with international leaders, including Cheplapharm, Engelhard, Sandoz and IBSA. Certified to the most exacting European standards, FarmaSyn’s prioritization of quality and patient trust has established it as a dependable partner for healthcare providers and patients in Greece.

Nikolaos Makrigiannis, Business Development Manager, FarmaSyn SA